Nirsevimab: The Hidden Costs

被引：4
|
作者：
Neumann, Samantha [1 ,2 ]
Alverson, Brian [1 ,2 ]
机构：
[1] Nemours Childrens Hlth, Wilmington, DE USA
[2] Thomas Jefferson Univ, Sidney Kimmel Med Coll, Philadelphia, PA USA
来源：
HOSPITAL PEDIATRICS | 2024年 / 14卷 / 06期
关键词：
RESPIRATORY SYNCYTIAL VIRUS; INFANTS; RSV;
D O I：
10.1542/hpeds.2024-007739
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
[No abstract available]
引用
收藏
页码：e276 / e278
页数：3
相关论文
共 50 条
  • [21] Fc-mediated functions of nirsevimab complement direct respiratory syncytial virus neutralization but are not required for optimal prophylactic protection
    Brady, Tyler
    Cayatte, Corinne
    Roe, Tiffany L.
    Speer, Scott D.
    Ji, Hong
    Machiesky, Leeann
    Zhang, Tianhui
    Wilkins, Deidre
    Tuffy, Kevin M.
    Kelly, Elizabeth J.
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [22] Safety and Pharmacokinetics of Nirsevimab in Immunocompromised Children
    Domachowske, Joseph
    Hamren, Ulrika Wahlby
    Banu, Irfana
    Baronio, Roberta
    Basavaraju, Bhanu
    Koen, Anthonet
    Leach, Amanda
    Mankad, Vaishali S.
    Pannaraj, Pia S.
    Soler-Palacin, Pere
    Takas, Therese
    Mori, Masaaki
    Villafana, Tonya
    PEDIATRICS, 2024, 154 (04)
  • [23] Effectiveness of nirsevimab against RSV-bronchiolitis in paediatric ambulatory care: a test-negative case-control - control study
    Lassoued, Yannis
    Levy, Corinne
    Werner, Andreas
    Assad, Zein
    Bechet, Stephane
    Frandji, Bruno
    Batard, Christophe
    Cahn-Sellem, Fabienne
    Fafi, Ines
    Lenglart, Lea
    Aupiais, Camile
    Basmaci, Romain
    Cohen, Robert
    Ouldali, Naim
    LANCET REGIONAL HEALTH-EUROPE, 2024, 44
  • [24] Effectiveness of Nirsevimab Immunoprophylaxis Administered at Birth to Prevent Infant Hospitalisation for Respiratory Syncytial Virus Infection: A Population-Based Cohort Study
    Ezpeleta, Guillermo
    Navascues, Ana
    Viguria, Natividad
    Herranz-Aguirre, Mercedes
    Belloc, Sergio Enrique Juan
    Ballester, Juan Gimeno
    Muruzabal, Juan Carlos
    Garcia-Cenoz, Manuel
    Trobajo-Sanmartin, Camino
    Echeverria, Aitziber
    Martinez-Baz, Ivan
    Vera-Punzano, Noelia
    Casado, Itziar
    Lopez-Mendoza, Hector
    Ezpeleta, Carmen
    Castilla, Jesus
    VACCINES, 2024, 12 (04)
  • [25] Nirsevimab immunization's real-world effectiveness in preventing severe bronchiolitis: A test-negative case-control study
    Aguera, Marta
    Soler-Garcia, Aleix
    Alejandre, Carme
    Moussalam-Merino, Sara
    Sala-Castellvi, Pere
    Pons, Gemma
    Penela-Sanchez, Daniel
    Gonzalez-Grado, Carla
    Alsina-Rosell, Judit
    Climent, Carme
    Esteva, Cristina
    Fortuny, Claudia
    de-Sevilla, Mariona-F
    Garcia-Garcia, Juan-Jose
    Brotons, Pedro
    Balaguer, Albert
    Estrada, Josep
    Jordan, Iolanda
    Munoz-Almagro, Carmen
    Launes, Cristian
    PEDIATRIC ALLERGY AND IMMUNOLOGY, 2024, 35 (06)
  • [26] Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants
    Drysdale, Simon B.
    Cathie, Katrina
    Flamein, Florence
    Knuf, Markus
    Collins, Andrea M.
    Hill, Helen C.
    Kaiser, Friedrich
    Cohen, Robert
    Pinquier, Didier
    Felter, Christian T.
    Vassilouthis, Natalya C.
    Jin, Jing
    Bangert, Mathieu
    Mari, Karine
    Nteene, Rapi
    Wague, Sophie
    Roberts, Michelle
    Tissieres, Pierre
    Royal, Simon
    Faust, Saul N.
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 389 (26) : 2425 - 2435
  • [27] Respiratory Syncytial Virus Vaccine and Nirsevimab Uptake Among Pregnant People and Their Neonates
    Blauvelt, Christine A.
    Zeme, Molly
    Natarajan, Aishwarya
    Epstein, Adrienne
    Roh, Michelle E.
    Morales, Amayrani
    Bourdoud, Nadia
    Flaherman, Valerie J.
    Prahl, Mary K.
    Gaw, Stephanie L.
    JAMA NETWORK OPEN, 2025, 8 (02) : e2460735
  • [28] Cost-Effectiveness and Public Health Impact of Universal Prophylaxis with Nirsevimab Against Respiratory Syncytial Virus (RSV) Infections in all Infants in Japan
    Noto, Shinichi
    Kieffer, Alexia
    Soudani, Samira
    Arashiro, Takeshi
    Tadera, Chiho
    Eymere, Sebastien
    Lemanski, Tobiasz
    Wang, Xinyu
    INFECTIOUS DISEASES AND THERAPY, 2025, 14 (04) : 847 - 865
  • [29] Analysis of Beyfortus® (Nirsevimab) Immunization Campaign: Effectiveness, Biases, and ADE Risks in RSV Prevention
    Banoun, Helene
    CURRENT ISSUES IN MOLECULAR BIOLOGY, 2024, 46 (09) : 10369 - 10395
  • [30] Implementation of the first respiratory syncytial (RSV) immunization campaign with nirsevimab in an autonomous community in Spain
    Martin, Jaime Jesus Perez
    Moreno, Matilde Zornoza
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2024, 20 (01)
12345